International Journal of Stroke
Rationale and design of a phase 3b, prospective, randomized, open label, blinded-endpoint, multicenter trial of the efficacy and safety of urokinase thrombolysis comparing with antiplatelet agents for patients with minor stroke
International Journal of Stroke, Volume 17, Issue 4, Page 474-477, April 2022. RationaleMinor ischemic stroke attack has taken a significant part of cerebrovascular disease burden. Benefits of thrombolysis in minor stroke is under debates and the use o…
International Journal of Stroke
Cognitive impact of cerebral microbleeds in patients with symptomatic small vessel disease
International Journal of Stroke, Volume 17, Issue 4, Page 415-424, April 2022. Background and aimWhether cerebral microbleeds cause cognitive impairment remains uncertain. We analyzed whether cerebral microbleeds are associated with cognitive dysfuncti…
International Journal of Stroke
WITHDRAWN: Decompressive surgery in patients with malignant middle cerebral artery infarction: A randomized, controlled trial in a Turkish population (Demitur trial)
International Journal of Stroke, Ahead of Print.